Chinese firm to build home-grown CT

Article

A Chinese company has begun building low-priced CT scanners, which could compete in the country for sales with systems marketed by such multinational vendors as Shimadzu, GE, and Siemens. Shenyang Neu-Alpine Software has been granted permission by the

A Chinese company has begun building low-priced CT scanners, which could compete in the country for sales with systems marketed by such multinational vendors as Shimadzu, GE, and Siemens. Shenyang Neu-Alpine Software has been granted permission by the State Pharmaceutical Administration Commission to begin mass production of CT scanners, according to Comline Computer Wire. The company is believed to be the first Chinese firm manufacturing its own CT scanners, according to sources familiar with the Chinese market.

The company plans to win market share by selling its scanners at a considerable price discount compared with products marketed by importers. Neu-Alpine Software's scanners will list at $192,700, while imported machines cost around $360,000, according to Comline. The company plans to manufacture 100 CT scanners annually.

Although the company's scanners will enjoy a major price advantage, Chinese companies do not have a stellar record in producing complex medical imaging machinery. Chinese manufacturers have been competing in MRI since the early 1990s, but have not taken a substantial share of the Chinese market, according to observers.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.